Tuberculosis in the Netherlands
Report of the joint ECDC and WHO review of the tuberculosis prevention and care system in the Netherlands, 24–28 June 2019.
Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data
Dadu A, Hovhannesyan A, Ahmedov S, van der Werf MJ, Dara M.
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected in 2018 and 2019 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration. The monitoring questionnaire was disseminated to the 53 countries that are part of the WHO European Region, plus Kosovo and Liechtenstein via an online survey.
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.
Programmatic management of latent tuberculosis infection in the European Union
Programmatic management of latent tuberculosis infection (LTBI) is a key component of the global tuberculosis (TB) elimination strategy. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area (EU/EEA).
HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets
Brown, A.E., Hayes, R., Noori, T., Azad, Y., Amato-Gauci, A.J., Pharris, A., Delpech, V.C., The Ecdc Dublin Declaration Monitoring Network
- Central Asia
- Czech Republic
- HIV infection
- Prevention and control
- Public health response
- The Republic of North Macedonia
- Transmission of disease
- United Kingdom